Market Highlights
The Crohn’s & Colitis Foundation of America (CCFA) stated, that over 1 Million Americans were diagnosed with Crohn's & ulcerative colitis disorders and diseases, with maximum of them aged above 30. Increasing occurrence of Crohn's disease has triggered a vigorous demand for its therapeutics.
The global Crohn’s disease market size is expected to register ~3.3% CAGR during the forecast period, 2019 to 2025.
A survey conducted by the US Center for Disease Control (CDC) has discovered that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually. The disease is highly predominant in developed countries, especially in individuals who smoke and consume alcohol.
Major factors leading to the growth of the market includes higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs. High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.
North America is expected to account for the largest share of the global Crohn’s disease Market in 2016, followed by Europe, the region will continue to lead the pack during the forecast period. The emerging markets of China and India will also play a key role in driving growth in the long term, primarily due to the anticipated strong uptake of Remicade over the forecast period.
Global Crohn’s Disease Market Players:
Key players profiled in the report are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, and Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc., Johnson & Johnson Services, Inc., Ferring B.V.
Dholera SIR Project to gain as Gujarat Scored top Position for Gujarat has been ranked as the #1 state by the World Bank on the "Ease of Doing Business in India Index", the first ever survey conducted of its kind.
Dholera shall attract investments by the virtue of being the first and fastest developing dholera smart city of India.Contact Us : 7096961241, 42 , 43 , 44 , 45, 46, 47, 48, 49, 50, 83, 84, 85For more info please visit our site: https://www.smart-homes.in/Watch Our Videos and Subscribe Channel: https://www.youtube.com/c/SmartHomesInfrastructure
Not interested in this ad
Seen this ad multiple times
Infusion Pump Market Analysis By Size, Share, Key Players, Trends, Insights, Dynamics, Future Outlook, Applications and Segmentation, Forecast to 2023
The Global Infusion Pump Market Size and share is anticipated to reach USD 9.71 billion with expanding at a CAGR of 5% throughout the forecast period (2017-2023).
The Infusion pump market size to witness significant growth due to growth in the burgeoning healthcare sector and increasing occurrences of fatal & chronic diseases, globally.
Rising investments in R by the leading market players to bring about further innovations and advancements in their existing product range drive the growth of the infusion pump market.
